• Je něco špatně v tomto záznamu ?

Gastric pH in rats: Key determinant for preclinical evaluation of pH-dependent oral drug absorption

M. Šíma, N. Kutinová-Canová, P. Ryšánek, J. Hořínková, D. Moškořová, O. Slanař

. 2019 ; 120 (1) : 5-9.

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19021890

Grantová podpora
Progres Q25 Univerzita Karlova v Praze
SVV 260373 Univerzita Karlova v Praze

Data on gastric pH in rats to be used in preclinical models for pH-dependent drug absorption are still limited or contradictory. The aim of this study was to describe gastric pH in rats at fasted state and to evaluate its changes induced by pentagastrin or omeprazole in order to mimic gastric pH at fasted and fed human subjects. Twenty Wistar rats, fasting for 12 h, were randomly assigned into four treatment groups (n=5): control, pre-treated with omeprazole 2 h before pH measurement, pre-treated with omeprazole 12 h before pH measurement, and pre-treated with pentagastrin 20 min before pH measurement. An incision on the stomach wall was made in anesthetized animals, and pH of gastric juice was measured. The observed pH values were significantly different among groups (p=0.0341), with the median (IQR) values of gastric pH of 3.5 (2.7-4.2), 6.7 (4.7-7.0), 5.6 (3.5-6.4) and 2.2 (1.6-3.1) in control, omeprazole 2 h, omeprazole 12 h and pentagastin group, respectively. We recommend using short interval pentagastrin and 2 h omeprazole pre-treatment in fasting animals to model similar gastric pH as is expected in human fasted and fed state pharmacokinetic studies, respectively.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19021890
003      
CZ-PrNML
005      
20190805142512.0
007      
ta
008      
190607s2019 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.14712/23362936.2019.5 $2 doi
035    __
$a (PubMed)31103048
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Šíma, Martin $u Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $7 xx0222901
245    10
$a Gastric pH in rats: Key determinant for preclinical evaluation of pH-dependent oral drug absorption / $c M. Šíma, N. Kutinová-Canová, P. Ryšánek, J. Hořínková, D. Moškořová, O. Slanař
520    9_
$a Data on gastric pH in rats to be used in preclinical models for pH-dependent drug absorption are still limited or contradictory. The aim of this study was to describe gastric pH in rats at fasted state and to evaluate its changes induced by pentagastrin or omeprazole in order to mimic gastric pH at fasted and fed human subjects. Twenty Wistar rats, fasting for 12 h, were randomly assigned into four treatment groups (n=5): control, pre-treated with omeprazole 2 h before pH measurement, pre-treated with omeprazole 12 h before pH measurement, and pre-treated with pentagastrin 20 min before pH measurement. An incision on the stomach wall was made in anesthetized animals, and pH of gastric juice was measured. The observed pH values were significantly different among groups (p=0.0341), with the median (IQR) values of gastric pH of 3.5 (2.7-4.2), 6.7 (4.7-7.0), 5.6 (3.5-6.4) and 2.2 (1.6-3.1) in control, omeprazole 2 h, omeprazole 12 h and pentagastin group, respectively. We recommend using short interval pentagastrin and 2 h omeprazole pre-treatment in fasting animals to model similar gastric pH as is expected in human fasted and fed state pharmacokinetic studies, respectively.
650    _2
$a zvířata $7 D000818
650    12
$a žaludeční sliznice $7 D005753
650    _2
$a lidé $7 D006801
650    _2
$a koncentrace vodíkových iontů $7 D006863
650    _2
$a modely u zvířat $7 D023421
650    12
$a omeprazol $x farmakokinetika $7 D009853
650    12
$a inhibitory protonové pumpy $x farmakokinetika $7 D054328
650    _2
$a náhodné rozdělení $7 D011897
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    12
$a žaludek $x chemie $7 D013270
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kutinová-Canová, Nikolína $u Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $7 xx0103768
700    1_
$a Ryšánek, Pavel $u Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $7 xx0239090
700    1_
$a Hořínková, Jana $u Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $7 xx0228030
700    1_
$a Moškořová, Denisa $u Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $7 xx0239091
700    1_
$a Slanař, Ondřej $u Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $7 xx0058262
773    0_
$w MED00013414 $t Prague medical report $x 1214-6994 $g Roč. 120, č. 1 (2019), s. 5-9
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31103048 $y Pubmed
856    41
$u https://pmr.lf1.cuni.cz/media/pdf/pmr_2019120010005.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 7 $c 1071 $y 4 $z 0
990    __
$a 20190607 $b ABA008
991    __
$a 20190805142635 $b ABA008
999    __
$a ok $b bmc $g 1429470 $s 1060245
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 120 $c 1 $d 5-9 $i 1214-6994 $m Prague Medical Report $n Prague Med. Rep. $x MED00013414
GRA    __
$a Progres Q25 $p Univerzita Karlova v Praze
GRA    __
$a SVV 260373 $p Univerzita Karlova v Praze
LZP    __
$b NLK111 $a Pubmed-20190607

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace